Euroapi SAS Market Cap ($81.43 Million)
Market Cap & Net Worth: Euroapi SAS (EAPI)
Euroapi SAS market cap. Euroapi SAS (PA:EAPI) has a market capitalization of $81.43 Million (€69.65 Million) as of November 8, 2026. Listed on the PA stock exchange, this France-based company holds position #19761 globally and #301 in its home market, demonstrating a -1.12% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Euroapi SAS's stock price €0.80 by its total outstanding shares 95570106 (95.57 Million). Also see EAPI cash flow conversion for how efficiently the company converts equity into cash flow.
Euroapi SAS Market Cap History (2022–2026)
Euroapi SAS market cap history from 2022 to 2026. Data shows change from $1.55 Billion to $89.05 Million (-46.64% CAGR). Check Euroapi SAS stock quote for real-time trading data and today's change.
Index Memberships
Euroapi SAS is a constituent of 6 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
CAC Mid 60
CACMD
|
$186.61 Billion | 0.04% | #50 of 55 |
|
CAC Mid & Small
CACMS
|
$222.25 Billion | 0.04% | #90 of 119 |
|
CAC All-Tradable
CACT
|
$2.82 Trillion | 0.00% | #150 of 179 |
|
CAC All-Tradable Net Total Return
CACTN
|
$2.82 Trillion | 0.00% | #150 of 179 |
|
CAC All Tradable Gross Total Return
CACTR
|
$2.82 Trillion | 0.00% | #150 of 179 |
|
CAC Health Care
FRHC
|
$268.00 Billion | 0.03% | #24 of 36 |
Weight: Euroapi SAS's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Euroapi SAS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Euroapi SAS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Euroapi SAS equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.30x
Euroapi SAS's market cap is 0.30 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $1.55 Billion | $980.90 Million | -$15.00 Million | 1.58x | N/A |
| 2023 | $640.22 Million | $1.02 Billion | -$189.70 Million | 0.63x | N/A |
| 2024 | $321.79 Million | $919.20 Million | -$130.60 Million | 0.35x | N/A |
| 2025 | $253.63 Million | $848.20 Million | -$211.20 Million | 0.30x | N/A |
Competitor Companies of EAPI by Market Capitalization
Companies near Euroapi SAS in the global market cap rankings as of November 8, 2026. Also see Euroapi SAS asset portfolio for a full breakdown of the balance sheet.
Key companies related to Euroapi SAS by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #530 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #567 globally with a market cap of $47.07 Billion USD ( CN¥321.69 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #609 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #530 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.61 |
| #567 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $47.07 Billion | CN¥50.43 |
| #609 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.80 |
Market Capitalization of Euroapi SAS (2022–2026)
Market capitalization of Euroapi SAS from 2022 to today. Between 2022 and today, Euroapi SAS's market cap moved from $1.55 Billion to $ 89.05 Million, with a yearly change of -46.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €89.05 Million | -64.89% |
| 2025 | €253.63 Million | -21.18% |
| 2024 | €321.79 Million | -49.74% |
| 2023 | €640.22 Million | -58.63% |
| 2022 | €1.55 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 8th, 2026 the market cap of Euroapi SAS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $81.43 Million USD |
| MoneyControl | $81.43 Million USD |
| MarketWatch | $81.43 Million USD |
| marketcap.company | $81.43 Million USD |
| Reuters | $81.43 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Euroapi SAS
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that use solid phase chemistry; … Read more